Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fulda

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Current Pharmaceutical Design|February 10, 2009
Apoptosis pathways and neuroblastoma therapyS Fulda
Current Cancer Drug Targets|September 17, 2009
The PI3K/Akt/mTOR pathway as therapeutic target in neuroblastomaS Fulda
Leukemia|January 11, 2012
Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignanciesS Fulda
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Diaries of sleep behavior]S Fulda
International Review of Cell and Molecular Biology|February 21, 2017
Smac Mimetics to Therapeutically Target IAP Proteins in CancerS Fulda
Leukemia|February 4, 2014
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunitiesS Fulda
Leukemia|November 29, 2008
Inhibitor of apoptosis proteins in hematological malignanciesS Fulda
Klinische Padiatrie|September 24, 2010
Cell death and survival signaling in oncogenesisS Fulda
Oncogene|March 12, 2013
Regulation of cell migration, invasion and metastasis by IAP proteins and their antagonistsS Fulda
Cell Death and Differentiation|June 11, 2013
The dark side of TRAIL signalingS Fulda
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Current Pharmaceutical Design|February 10, 2009
Apoptosis pathways and neuroblastoma therapyS Fulda
Current Cancer Drug Targets|September 17, 2009
The PI3K/Akt/mTOR pathway as therapeutic target in neuroblastomaS Fulda
Leukemia|January 11, 2012
Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignanciesS Fulda
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Diaries of sleep behavior]S Fulda
International Review of Cell and Molecular Biology|February 21, 2017
Smac Mimetics to Therapeutically Target IAP Proteins in CancerS Fulda
Leukemia|February 4, 2014
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunitiesS Fulda
Leukemia|November 29, 2008
Inhibitor of apoptosis proteins in hematological malignanciesS Fulda
Klinische Padiatrie|September 24, 2010
Cell death and survival signaling in oncogenesisS Fulda
Oncogene|March 12, 2013
Regulation of cell migration, invasion and metastasis by IAP proteins and their antagonistsS Fulda
Cell Death and Differentiation|June 11, 2013
The dark side of TRAIL signalingS Fulda
Pageof 16